GLP-1 Drugs Are About to Destroy Medicare Costs

Medicare is positioning to cover GLP-1 drugs for weight loss through two programs. Starting July 1, 2026 the Bridge program will provide access to GLP-1 weight-loss drugs — including Foundayo, Wegovy, and Zepbound — for eligible beneficiaries at $50/month. But there are important details the headlines aren't telling you about the tradeoffs of covering these types of medications. RELATED VIDEO:    • The GLP-1 Program Medicare Headlines Are M...   FOR PROVIDERS: Here is the link for information providers need for this process: https://www.cms.gov/files/document/gl... MEDICARE PLAYBOOK DOWNLOAD: https://theretirementnerds.com/medica... 📋 CMS GLP-1 Bridge FAQ: https://www.cms.gov/medicare/coverage... 📋 KFF Medicare GLP-1 Spending Trends: https://www.kff.org/medicare/recent-t... 📋 KFF Medicaid GLP-1 Spending: https://www.kff.org/medicaid/medicaid... 🔗 Get help with Medicare: https://theretirementnerds.com/ ============================= Send me a message! [email protected] ============================= ============================================================ Join our newsletter for monthly tips, book recommendations, and personal stories! https://theretirementnerds.com/newsle... ============================================================ 📌 Timestamps: 0:00 Intro 0:47 GLP-1 Medicare Cost Problem 1:11 Policy Decisions 2:27 The Two Programs 2:48 Bridge Details 4:20 Expensive Drug Problems 7:54 Impact on Advantage vs Supplement 10:31 Bigger Picture Problem 11:50 Where to Get Help #Medicare #GLP1 #Wegovy #Zepbound #MedicareDrugs #RetirementNerds Federal Disclaimer: We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all your options.